Although initial studies focused on deciphering how FLCN loss results in BHD-associated renal tumors, evidence accumulated during the last decade indicate that FLCN is a pleiotropic protein implicated in multiple cellular processes. The gene discussed is FLCN; the disease is Birt-Hogg-Dube syndrome.